EPISODE · Jun 16, 2025 · 23 MIN
Renal: Renal Cell Carcinoma: Free MSRA Podcast
from Pass the MSRA: Free Podcasts · host Pass the MSRA
🎧 FREE MSRA PODCAST – Renal Cell Carcinoma (RCC): Rapid-Recall RevisionKidney cancer, demystified! We unpack RCC in the format you need: fast, focused, and full of clinical must-knows. Perfect for MSRA, UK practice, and beyond.🧠 Key Learning PointsDefinition• Renal Cell Carcinoma (RCC) = Most common kidney cancer in adults• Originates from the proximal renal tubule cells (lining the nephron)Epidemiology• 80% of kidney cancers are RCC• Peak age: 60–70 years, more common in men• Over 4,000 cases per year in the UK• Rising incidence, higher in deprived areas, lower in Asian/Black groupsRisk Factors• Smoking, obesity, hypertension• Genetics: von Hippel-Lindau (VHL), tuberous sclerosis• Chronic kidney disease, renal transplant• Male sex, older ageClinical Features• Classic triad (rare!): haematuria, flank pain, abdominal mass• Most common presentation: asymptomatic, found incidentally on scans• Other: fatigue, weight loss, fever, varicocele, leg swelling, signs of metastasis (lungs, bones)• Paraneoplastic syndromes: polycythaemia, hypercalcaemiaDiagnosis & Staging• Imaging: Abdominal CT (main), ultrasound, MRI as indicated• Bloods: Renal function, anaemia, calcium• Biopsy: If diagnosis uncertain or for metastatic/active surveillance cases• Staging: TNM system (Tumour, Node, Metastasis) – Stage 1–2 = localised – Stage 3 = local spread – Stage 4 = distant spreadManagement• Surgery: Partial or radical nephrectomy for localised tumours• Ablation or surveillance: For select small tumours• Advanced/metastatic disease: – Immunotherapy (e.g., nivolumab, ipilimumab) – Targeted therapy: TKIs (sunitinib, pazopanib), everolimus – Bisphosphonates for bone metastases – Radiotherapy: For isolated mets or palliation• Chemotherapy: Not usually effective• Long-term follow-up is crucialComplications• Metastases: Lungs, bones, liver• Local invasion: Pain, kidney impairment• Paraneoplastic syndromes• Prognosis: Heavily stage-dependent – 1-year survival: ~79% – 5-year: ~64% – 10-year: ~52% (UK data)• Best outcomes with early-stage diagnosisMemory Aid:“RCC = Renal Cancer Caught incidentally!”Think: “Triad is rare—most are silent.”TNM = The Next Move (for treatment)!📎 More Renal Cell Carcinoma Resources:📝 Revision Notes: https://www.passthemsra.com/topic/renal-cell-carcinoma-revision-notes/💬 Flashcards: https://www.passthemsra.com/topic/renal-cell-carcinoma-flashcards/🧠 Q&A Notes: https://www.passthemsra.com/topic/renal-cell-carcinoma-accordion-qa-notes/📝 Rapid Quiz: https://www.passthemsra.com/topic/renal-cell-carcinoma-rapid-quiz/🎯 Quiz Portal: https://www.passthemsra.com/quizzes/renal-cell-carcinoma/📚 Renal Course: https://www.passthemsra.com/courses/renal-for-the-msra/🏷️ #MSRA #RenalCellCarcinoma #KidneyCancer #MSRARevision #PassTheMSRA #FreeMSRA #Renal #CancerRevision #MSRAFlashcards #UKGuidelines #TNMStaging #Oncology #GPRevision
Embed this episode
Ready to play
Renal: Renal Cell Carcinoma: Free MSRA Podcast
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.